Flow cytometry results showed that anti-PD-L1 and radiotherapy both enhanced proliferation ability and cytotoxic ability of tumor-infiltrating T cells in CT26-ATM−/− tumors (Fig. 7F–K), while this effect was not observed in CT26-WT tumors (Fig. 7A–D). The gene discussed is DDX53; the disease is neoplasm.